Seeking Alpha

Enzon Pharmaceuticals (ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory...

Enzon Pharmaceuticals (ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory filing late yesterday that it's reducing its workforce from 19 employees to 12. It expects to incur about $1.3M in charges related to the reduction in force, due to cash expenditures for one-time employee termination benefits and associated costs. The company expects to record the charges and complete the reduction by the end of Q1.
Comments (1)
  • Brian Harper, CFA
    , contributor
    Comments (307) | Send Message
     
    Margins and earnings will be substantially higher than in the past. The co has huge NOLs and there's potential for the sale of drugs in development.
    4 Apr 2013, 12:17 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs